Angiotensin II infusion model of hypertension: Is there an important sympathetic component?

Hypertension

Volumn 59, Issue 3, 2012, Pages 539-541

  Lohmeier, Thomas E ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; SODIUM;

ADRENAL FUNCTION; ARTERIAL PRESSURE; EXPERIMENTAL MODEL; HUMAN; HYPERTENSION; KIDNEY FUNCTION; KIDNEY INNERVATION; NEUROENDOCRINE SYSTEM; NONHUMAN; NOTE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RENAL SYMPATHETIC NERVE ACTIVITY; SALT INTAKE; SODIUM RETENTION; SYMPATHETIC FUNCTION; SYMPATHETIC TONE; VASCULAR RESISTANCE;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; FEMALE; HYPERTENSION; KIDNEY; MALE; SODIUM CHLORIDE, DIETARY; SYMPATHETIC NERVOUS SYSTEM; TELEMETRY;

EID: 84857558973     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.188714     Document Type: Note

References (13)

1. Guild S-J, McBryde FD, Malpas SC, Barrett CJ. High dietary salt and angiotensin II chronically increase renal sympathetic nerve activity: a direct telemetric study. Hypertension. 2012;59:614-620.
2. Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev. 1990;70:963-985. (Pubitemid 20364820)
3. Carroll RG, Lohmeier TE, Brown AJ. Chronic angiotensin II infusion decreases renal norepinephrine overflow in the conscious dog. Hypertension. 1987;6:675-681.
4. Simplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment resistant hypertension (the Symplicity HTN-2 Trial): a randomized controlled trial. Lancet. 2011;376:1903-1909.
5. Bisognano JD, Bakris G, Nadim MK, Sanchez L, Kroon AA, Schafer J, de Leeuw PW, Sica DA. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the doubleblind, randomized, placebo-controlled Rheos Pivotal Trial. J Am Coll Cardiol. 2011;58:765-773.
6. Lohmeier TE, Iliescu R, Liu B, Henegar JR, Maric-Bilkan C, Irwin ED. Systemic and renal-specific sympathoinhibition in obesity hypertension. Hypertension. 2012;59:334-341.
7. Barrett CJ, Ramchandra R, Guild SL, Lala A, Budgett DM, Malpas SC. What sets the long-term level of renal sympathetic nerve activity: a role for angiotensin II and baroreflexes? Circ Res. 2003;92:133-1336.
8. Barrett CJ, Guild S-J, Ramchandra R, Malpas SC. Baroreceptor denervation prevents sympathoinhibition during angiotensin II-induced hypertension. Hypertension. 2005;46:1-5.
9. Lohmeier TE, Lohmeier JR, Haque A, Hildebrandt DA. Baroreflexes prevent neurally-induced sodium retention in angiotensin hypertension. Am J Physiol Regulatory Integrative Comp Physiol. 2000;279:R1437-R1448.
10. Yoshimoto M, Miki K, Fink GD, King A, Osborn JW. Chronic angiotensin II infusion causes differential responses in regional sympathetic nerve activity in rats. Hypertension. 2010;55:644-651.
11. McBryde FD, Guild S-J, Barrett CJ, Osborn JW, Malpas SC. Angiotensin II-based hypertension and the sympathetic nervous system: role of dose and increased dietary salt in rabbits. Exp Physiol. 2007;92.5:831-840. (Pubitemid 47283895)
12. Cowley AW Jr, DeClue JW. Quantification of baroreceptor influence on arterial pressure changes seen in primary angiotensin-induced hypertension. Circ Res. 1976;39:779-787.
13. Lohmeier TE, Dwyer TM, Hildebrandt DA, Irwin ED, Rossing MA, Serdar DJ, Kieval RS. Influence of prolonged baroreflex activation on arterial pressure in angiotensin hypertension. Hypertension. 2005;46: 1194-1200. (Pubitemid 41533025)